Gene identification and semisynthesis of the anti‐inflammatory oleanane‐type triterpenoid wilforlide A
New Phytologist · 2024
DOI: 10.1111/nph.19427 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Phytologist, 2024. Verfasst von Yuan Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Triterpenes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, the National Key R&D Program of China, General Program of National Natural Science Foundation of China.
Abstract (Originalsprache)
Wilforlide A is one of the main active constituents produced in trace amounts in Tripterygium wilfordii Hook F, which has excellent anti‐inflammatory and immune suppressive effects. Despite the seeming structural simplicity of the compound, the biosynthetic pathway of wilforlide A remains unknown. Gene‐specific expression analysis and genome mining were used to identify the gene candidates, and their functions were studied in vitro and in vivo . A modularized two‐step (M2S) technique and CRISPR–Cas9 methods were used to construct engineering yeast. Here, we identified a cytochrome P450, TwCYP82AS1, that catalyses C‐22 hydroxylation during wilforlide A biosynthesis. We also found that TwCYP712K1 to K3 can further oxidize the C‐29 carboxylation of oleanane‐type triterpenes in addition to friedelane‐type triterpenes. Reconstitution of the biosynthetic pathway in engineered yeast increased the precursor supply, and combining TwCYP82AS1 and TwCYP712Ks produced abrusgenic acid, which was briefly acidified to achieve the semisynthesis of wilforlide A. Our work presents an alternative metabolic engineering approach for obtaining wilforlide A without relying on extraction from plants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, China.
- National Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310014, China.
- School of Pharmacy, College of Medicine, Hangzhou Normal University, Hangzhou, 311121, China.
- School of Pharmaceutical Science, Capital Medical University, Beijing, 100069, China.
ORCID-Profile: Yuan Liu, Jiawei Zhou, Yun Lu, Zhouqian Jiang, Wei Gao, Xiaoyi Wu, Yifeng Zhang, Changli Liu
Förderung
- the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- the National Key R&D Program of China
- General Program of National Natural Science Foundation of China
- Youth Fund of the National Natural Science Foundation of China
- the Natural Science Foundation of Zhejiang
Zitieren
APA
Liu, Y., Zhou, J., Liu, P., Hu, T., Liu, X., Gao, J., Ma, L., Lu, Y., Li, D., Jiang, Z., Zhang, X., Huang, L., Gao, W., Wu, X., Zhang, Y., & Liu, C. (2024). Gene identification and semisynthesis of the anti‐inflammatory oleanane‐type triterpenoid wilforlide A. New Phytologist. https://doi.org/10.1111/nph.19427
Vancouver
Liu Y, Zhou J, Liu P, Hu T, Liu X, Gao J, et al. Gene identification and semisynthesis of the anti‐inflammatory oleanane‐type triterpenoid wilforlide A. New Phytologist. 2024. doi:10.1111/nph.19427
BibTeX
@article{Liu2024,
author = {Liu, Yuan and Zhou, Jiawei and Liu, Panting and Hu, Tianyuan and Liu, Xuan and Gao, Jie and Ma, Lin and Lu, Yun and Li, Dan and Jiang, Zhouqian and Zhang, Xianan and Huang, Luqi and Gao, Wei and Wu, Xiaoyi and Zhang, Yifeng and Liu, Changli},
title = {Gene identification and semisynthesis of the anti‐inflammatory oleanane‐type triterpenoid wilforlide A},
journal = {New Phytologist},
year = {2024},
doi = {10.1111/nph.19427}
}
EUVIMED